Continuing Education Activity

Labyrinthitis is an inflammation of the membranous labyrinth of the inner ear and typically presents with vertigo, nausea, vomiting, tinnitus, and/or hearing loss. It is normally caused by a bacterial or viral infection; however, it can be a manifestation of systemic autoimmune disease or human immunodeficiency virus in some cases. Although most patients achieve complete recovery, patients may be left with residual balance or hearing problems. Treatment is tailored to the etiology as well as symptom control. Although most patients will achieve complete recovery, patients may be left with residual balance or hearing problems. This activity reviews the evaluation and treatment of labyrinthitis and highlights the role of the interprofessional team in the care of patients with this condition.

Objectives:

• Identify the different causes of labyrinthitis.
• Explain the common examination findings associated with labyrinthitis.
• Outline the treatment options for the different etiologies of labyrinthitis.
• Summarize the importance of communication and coordination amongst the interprofessional team to enhance the care of patients with labyrinthitis.

Introduction

Labyrinthitis is an inflammation of the membranous labyrinth of the inner ear and typically presents with vertigo, nausea, vomiting, tinnitus, and/or hearing loss.[1] There is little epidemiological data about labyrinthitis; however, the incidence appears to increase with age.[2] Many other serious conditions can mimic the symptoms of labyrinthitis, such as a cerebrovascular accident (CVA), which is why it is crucial to perform a thorough history, examination, and investigations before diagnosing labyrinthitis. It is normally caused by a bacterial or viral infection; however, it can be a manifestation of systemic autoimmune disease or human immunodeficiency virus (HIV).[3][4] Treatment is tailored to the etiology as well as symptom control. Although most patients will achieve complete recovery, patients may be left with residual balance or hearing problems.

Anatomy

The inner ear consists of two structures: the bony labyrinth and the membranous labyrinth. The bony labyrinth is a collection of bony cavities within the skull's temporal bone. It has three main parts, the vestibule, cochlea, and three semicircular canals.[5] 

All three of these structures contain a substance known as perilymph.[6] The membranous labyrinth is located within the bony labyrinth and consists of four structures: the saccule, utricle, semicircular ducts, and cochlear duct. These are all filled with a substance known as endolymph. The inner ear has two connections with the middle ear and two connections with the central nervous system. The oval window connects the vestibule to the middle ear, and the round window connects the cochlear duct to the middle ear. The internal auditory canal and cochlear aqueduct connect the inner ear and central nervous system (CNS).[6]

Etiology

Labyrinthitis is an inflammation of the membranous labyrinth. It can be caused by viruses, bacteria, or systemic diseases.[3] In rare cases, it can result in labyrinthitis ossificans, wherein pathological new bone formation occurs within the membranous labyrinth.[7] Vestibular neuritis (also termed vestibular neuronitis) is often used interchangeably with labyrinthitis as the symptoms and clinical picture are extremely similar. However, true vestibular neuritis is inflammation confined to the vestibular nerve itself, without membranous labyrinth inflammation.[8] 

Viral Labyrinthitis

The most common cause of labyrinthitis is secondary to a viral upper respiratory tract infection. Labyrinthitis secondary to maternal rubella or cytomegalovirus (CMV) infections is one of the most common causes of congenital deafness. In the post-natal period, mumps and measles are the leading causes of viral hearing loss.[9][10][11][12] Ramsay-Hunt syndrome, also known as herpes zoster oticus, is caused when a latent varicella-zoster virus infection becomes reactivated, often years after the primary viral infection.[13] This classically produces a vesicular rash, usually in the oral mucosa or ear, along with peripheral facial nerve paralysis. The virus can also involve the vestibular and cochlear nerves in 25% of cases.[14] Finally, although the exact etiology of sudden sensorineural hearing loss (SNHL) remains unknown,[15] some research points towards a CMV inflammatory protein-mediated cause.[16] 

Bacterial Labyrinthitis

Bacterial labyrinthitis typically arises from either bacterial meningitis (20% of children with bacterial meningitis will develop auditory or vestibular symptoms) or otitis media.[17][18] The inflammation can occur via two different mechanisms. In serous labyrinthitis, the inflammation is secondary to bacterial toxins and/or host cytokines and inflammatory mediators passing into the membranous labyrinth via the round or oval window.[19] Suppurative labyrinthitis is inflammation caused directly by a bacterial infection. This will have entered the inner ear through the aforementioned oval window or round window, connecting the inner ear to the middle ear or via the central nervous system through the cochlear aqueduct or auditory canal. The round window is the most common entry point. They may also arise from acquired and congenital defects in the bony labyrinth.[5]

Autoimmune Labyrinthitis

Labyrinthitis has been demonstrated to be a rare complication of both polyarteritis nodosa and granulomatosis with polyangiitis.[20][21]

HIV/ Syphilis

Both syphilis and HIV have been associated with labyrinthitis. However, there is limited research as to whether the inflammation is caused by opportunistic infections as a result of the HIV-related immunosuppression or the virus itself.[22]

Epidemiology

There is little research into the incidence and prevalence of labyrinthitis, however, in South Korea, the prevalence of vestibular dysfunction varied from 3.1% to 35.4%, and the incidence increased with age.[2] Viral labyrinthitis is the most common form and is usually secondary to an upper respiratory tract infection.[3] It typically presents in adults aged 30-60 and is twice as common in females.[23] 

Suppurative bacterial labyrinthitis, as a complication of bacterial meningitis, is the commonest cause of deafness in children under age 2. Fortunately, this is exceedingly rare in the post-antibiotic era. Otogenic suppurative labyrinthitis can occur at any age and is typically found in cholesteatoma or secondary to untreated, longstanding otitis media.[19][24]

History and Physical

When taking a history from a patient with suspected labyrinthitis, it is important to screen for risk factors. These include recent viral infections (commonly upper respiratory tract infections), cholesteatoma or history of ear surgery, history of temporal bone or skull fracture, meningitis, and acute/chronic otitis media.

Nausea, vomiting, and severe ‘room spinning’ vertigo are the most common symptoms of labyrinthitis.[1] Initial vertigo rarely lasts longer than 72 hours; however, balance issues and occasional brief episodes of vertigo may persist for several weeks. Patients may also complain of hearing loss or tinnitus; this clinically differentiates labyrinthitis from vestibular neuritis, which is not associated with any auditory symptoms.[19] Targeted questioning regarding neurological symptoms such as numbness, weakness, dysphagia, dysarthria, and facial pain is crucial as these could indicate a CVA affecting the brain stem.[4] It is also important to clarify the number of episodes of ‘room spinning vertigo. Meniere disease must also be in the differential diagnosis if it has occurred more than once.[25]

On examination, patients will often display nystagmus; the fast phase will move away from the affected ear. Patients may also present with gait and balance disturbances; therefore, both Romberg’s and tandem gait are critical components of the required comprehensive neurological examination (including cerebellar and meningeal tests). Rinne and Weber hearing tests will likely demonstrate sensorineural hearing loss in the affected ear, and formal audiological evaluation is required if the patient reports any hearing abnormalities. Otoscopy may give clues to the etiology of the disease, e.g., otitis media or cholesteatoma. Finally, if querying bacterial meningitis, thoroughly examine the patient for the classical non-blanching rash.[26]

Evaluation

Audiometry is useful to assess the extent of sensorineural hearing loss. Specific investigations into the vestibular system (e.g., evoked myogenic potentials, electronystagmography, and rotary chair tests) are not indicated in the acute phase of the disease. However, they can be useful in assessing long-term compensation and residual deficits.

The laboratory tests should be tailored to the patient's symptoms and differential diagnoses. If the patient presents with severe vomiting, then a urea and electrolytes panel should be performed to assess whether electrolyte replacement needs to be initiated. If bacterial meningitis is suspected, then cerebrospinal fluid (CSF) cultures should be sent. Subsequently, consider HIV and syphilis serology in high-risk individuals or atypical presentations. Finally, consider autoimmune screens in patients with systemic symptoms or atypical presentations with negative serology.

Magnetic resonance imaging (MRI) and computed tomography (CT) imaging may be useful in ruling out alternative pathology. 13% of acoustic neuromas present with sudden hearing loss, which can be diagnosed using an MRI. Gadolinium-enhanced magnetic resonance imaging (GdMRI) is extremely accurate in predicting if a patient with bacterial meningitis will subsequently develop hearing loss, a complication in 14% of cases.[27][28][29]

Treatment / Management

Treatment must be tailored to the etiology and symptoms. Viral labyrinthitis should principally be managed by hydration and bed rest in the outpatient setting. However, patients must be counseled to seek further medical help if their symptoms deteriorate or they experience any neurological disturbances (e.g., weakness/numbness, diplopia, slurred speech, and gait disturbance).[30] There is currently little evidence regarding the use of antiviral medications and steroids.[31][32]

In bacterial labyrinthitis, antibiotic type and route depend on the source. Oral antibiotics are the first-line treatment for acute otitis media with an intact tympanic membrane; however, intravenous antibiotics may be necessary if the infection fails to respond. If bacterial meningitis is queried, then treat immediately with intravenous antibiotics while performing confirmatory imaging or CSF sampling.

The initial management of autoimmune labyrinthitis is corticosteroids. If patients are refractory to corticosteroid therapy, other immunomodulators may be considered, such as azathioprine, etanercept, or cyclophosphamide. These agents are often used in chronic conditions due to their reduced side effect profile compared to corticosteroids. However, this treatment should be overseen by a specialist.[33] If a patient’s serology is positive for syphilis or HIV, they should be started on the appropriate treatment and referred to a specialist.[34]

While suffering from initial vertigo, patients will want to lie motionless with their eyes closed. They must attempt to mobilize as soon as possible (even if this exacerbates their vertigo), which is believed to help with vestibular compensation and prognosis.[35]

Benzodiazepines and antihistamines can be used to treat initial vertigo. However, symptoms should not persist for longer than 72 hours. Therefore, only short courses of these medications should be prescribed as they can inhibit vestibular compensation. Antiemetics, such as prochlorperazine, should help control nausea and vomiting. Patients with sudden hearing loss should receive a course of corticosteroids and be referred to a specialist.

A small minority of patients may be left with residual tinnitus from sensorineural hearing loss. It is important to recognize the relationship between this and reactive depression and intervene early with treatments such as tinnitus re-training, tinnitus maskers, hearing aids, and/or biofeedback.[36][37]

Surgical intervention is only required in a minority of cases, for example, mastoidectomy in patients with cholesteatoma or severe mastoiditis. Occasionally patients may require drainage of effusions or myringotomy in labyrinthitis secondary to otitis media.

Once the acute labyrinthitis has resolved, patients may be left with persistent vestibular symptoms, which can seriously impact their life.[38] These patients should be referred for vestibular rehabilitation.[39]

Differential Diagnosis

Vestibular neuritis: This has a similar presentation to labyrinthitis but without hearing loss.[40]

Meniere disease: This also causes hearing loss and vertigo; however, the episodes are usually intermittent.[41]

Benign positional vertigo: This causes dizziness but not hearing loss, and patients will have a positive Dix-Hallpike test.[42]

Posterior fossa CVA: If a patient presents with any neurological signs, ataxia, hoarseness, dysarthria, or dysphagia, a CT/MRI head should be requested immediately to rule out a CVA.[43]

Acoustic neuromas/ vestibular schwannomas: These can be visualized using a GdMRI.[44]

Inner ear malformations: e.g. (missing crura of the stapes, atresia, abnormal incus): This typically presents with progressive hearing loss and can be diagnosed using CT or MRI imaging.[45]

Temporal bone fracture: This should be considered if there is a recent history of head trauma and can be confirmed with CT imaging.[46]

Inner ear hemorrhage: Commonly associated with trauma and easily demonstrated on MRI.[47]

Temporal bone neoplasm: Usually presents with cranial nerve deficits or facial paralysis and should be investigated with MRI and/or CT.[48]

Multiple sclerosis: This is more likely to present alongside other systemic symptoms such as spasticity or signs of optic neuritis.[49]

Pertinent Studies and Ongoing Trials

Superoxide dismutase has been shown to limit the hearing loss and prevent labyrinthitis ossificans in gerbils with bacterial meningitis. Tnf-alpha inhibitors appear to reduce postmeningitic cochlear injury and hearing loss.[50][51] There is also some evidence suggesting that corticosteroid therapy in pneumococcal meningitis may prevent labyrinthitis ossificans. Research into intra-tympanic corticosteroids as a superior therapeutic administration route has also shown promising results.[52] Finally, cochlear microperfusion and antioxidant therapy have shown some potential as adjuvant therapies.[53][54][55]

Prognosis

The acute vertigo of labyrinthitis should resolve within a couple of days; however, milder symptoms may persist for several weeks. The prognosis is usually good if the patient has no serious neurological sequelae. However, neurological complications may require further interventions, and the prognosis becomes more guarded. For example, ventriculoperitoneal shunts may be required in patients with hydrocephalus secondary to bacterial meningitis.[56] Patients who receive a prolonged course of benzodiazepines and/or antihistamines to treat their vertigo appear to have delayed vestibular recovery. Additionally, suppurative labyrinthitis is more likely to cause permanent hearing impairment.

Complications

Bilateral vestibular hypofunction is a debilitating complication associated with bilateral labyrinthitis, most commonly caused by bacterial meningitis. It can result in visual impairment (oscillopsia) and impaired spatial awareness, often leaving patients reliant on mobility aids.[57] After severe cases of labyrinthitis, some patients may be left with hearing loss or tinnitus, which can be managed with a hearing aid or tinnitus-specific therapies.[36] 

Complete deafness is a rare complication of bilateral labyrinthitis, usually caused by bacterial meningitis. Labyrinthitis ossificans is recognized as a complication of suppurative labyrinthitis.[58] If bacterial labyrinthitis is not treated effectively, there is the risk of it developing into mastoiditis. This condition typically responds well to IV antibiotics; however, it can result in mastoidectomy with tympanoplasty in severe cases.[59] Finally, labyrinthectomy may be required to terminate the disease process in rare cases of labyrinthitis secondary to cholesteatoma.[59]

Deterrence and Patient Education

Labyrinthitis is often secondary to another infection, such as otitis media or meningitis. Therefore early diagnosis and effective management of these is important to prevent (or minimize the risk of) the development of labyrinthitis or at least minimize the risk of long-term complications. It is also key that populations are up to date with their vaccinations to reduce the risk of contracting measles, mumps, or rubella.

Patients with vertigo should be encouraged to attempt mobilizing as soon as possible, as this is believed to help with vestibular compensation and prognosis.[35] Patients who receive a prolonged course of benzodiazepines and/or antihistamines to treat their vertigo appear to have delayed vestibular recovery.

Enhancing Healthcare Team Outcomes

The interprofessional team is crucial in delivering optimum care for a patient with labyrinthitis. Firstly, it is key that primary and secondary care clinicians are well aware of both the signs and symptoms of labyrinthitis and the other common/ serious differential diagnoses. This will ensure that the patient receives prompt and effective management and that potentially life-threatening conditions that can mimic labyrinthitis, such as cerebellar CVA, are not missed. 

Both nurses and pharmacists are essential in the initial management of a patient with labyrinthitis and, therefore, must have a good understanding of the condition. For example, nursing staff must be aware that the patient could be at high risk of falls and may need assistance with transfers due to vertigo. They may also take much longer completing tasks and should not be rushed. Pharmacists should advise on the most appropriate medications to help treat the patient's symptoms, e.g., nausea and vertigo. For example, benzodiazepines and antihistamines to manage acute vertigo should only be prescribed short-term as they can hinder vestibular recovery. They should also be aware of medications that can cause symptoms that mimic those of labyrinthitis when taking a drug history, as this is a cause that is occasionally overlooked. Aby concerns regarding the patient's medication regimen, including adverse effects or interactions, should be communicated to the prescribing clinician for remediation. Nurses must likewise assist in monitoring the patient and liaise between various team members. This interprofessional approach will yield the best patient results with the fewest adverse events or outcomes. [Level 5]

Patients can be left with residual vestibular symptoms, which severely impact their quality of life. This is when input from both occupational and physiotherapists is essential. Occupational therapists can perform assessments of the home environment and implement changes to improve patient safety and maintain quality of life. While physiotherapists can offer vestibular rehabilitation. After 1 or 2 sessions of vestibular rehabilitation, symptoms can be significantly improved or may be eliminated.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Wipperman J. Dizziness and vertigo. Prim Care. 2014 Mar;41(1):115-31. [PubMed: 24439886]

2.

Koo JW, Chang MY, Woo SY, Kim S, Cho YS. Prevalence of vestibular dysfunction and associated factors in South Korea. BMJ Open. 2015 Oct 26;5(10):e008224. [PMC free article: PMC4636645] [PubMed: 26503384]

3.

Thompson TL, Amedee R. Vertigo: a review of common peripheral and central vestibular disorders. Ochsner J. 2009 Spring;9(1):20-6. [PMC free article: PMC3096243] [PubMed: 21603405]

4.

Ortiz de Mendivil A, Alcalá-Galiano A, Ochoa M, Salvador E, Millán JM. Brainstem stroke: anatomy, clinical and radiological findings. Semin Ultrasound CT MR. 2013 Apr;34(2):131-41. [PubMed: 23522778]

5.

Sennaroğlu L, Bajin MD. Classification and Current Management of Inner Ear Malformations. Balkan Med J. 2017 Sep 29;34(5):397-411. [PMC free article: PMC5635626] [PubMed: 28840850]

6.

Ekdale EG. Form and function of the mammalian inner ear. J Anat. 2016 Feb;228(2):324-37. [PMC free article: PMC4718163] [PubMed: 25911945]

7.

Lin HY, Fan YK, Wu KC, Shu MT, Yang CC, Lin HC. The incidence of tympanogenic labyrinthitis ossificans. J Laryngol Otol. 2014 Jul;128(7):618-20. [PubMed: 25075947]

8.

Jeong SH, Kim HJ, Kim JS. Vestibular neuritis. Semin Neurol. 2013 Jul;33(3):185-94. [PubMed: 24057821]

9.

Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008 Mar 15;371(9616):932-44. [PubMed: 18342688]

10.

Moss WJ. Measles. Lancet. 2017 Dec 02;390(10111):2490-2502. [PubMed: 28673424]

11.

Yazigi A, De Pecoulas AE, Vauloup-Fellous C, Grangeot-Keros L, Ayoubi JM, Picone O. Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Fetal Neonatal Med. 2017 Feb;30(3):274-278. [PubMed: 27002428]

12.

Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol. 2018 Apr;42(3):149-154. [PubMed: 29503048]

13.

Jeon Y, Lee H. Ramsay Hunt syndrome. J Dent Anesth Pain Med. 2018 Dec;18(6):333-337. [PMC free article: PMC6323042] [PubMed: 30637343]

14.

Hato N, Kisaki H, Honda N, Gyo K, Murakami S, Yanagihara N. Ramsay Hunt syndrome in children. Ann Neurol. 2000 Aug;48(2):254-6. [PubMed: 10939578]

15.

Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif. 2011 Sep;15(3):91-105. [PMC free article: PMC4040829] [PubMed: 21606048]

16.

Schraff SA, Schleiss MR, Brown DK, Meinzen-Derr J, Choi KY, Greinwald JH, Choo DI. Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury. Otolaryngol Head Neck Surg. 2007 Oct;137(4):612-8. [PubMed: 17903579]

17.

Nadol JB. Hearing loss as a sequela of meningitis. Laryngoscope. 1978 May;88(5):739-55. [PubMed: 642669]

18.

Wu JF, Jin Z, Yang JM, Liu YH, Duan ML. Extracranial and intracranial complications of otitis media: 22-year clinical experience and analysis. Acta Otolaryngol. 2012 Mar;132(3):261-5. [PubMed: 22224578]

19.

Jang CH, Park SY, Wang PC. A case of tympanogenic labyrinthitis complicated by acute otitis media. Yonsei Med J. 2005 Feb 28;46(1):161-5. [PMC free article: PMC2823044] [PubMed: 15744821]

20.

Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum. 2004 Oct;34(2):544-8. [PubMed: 15505770]

21.

Harris JP, Ryan AF. Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg. 1995 Jun;112(6):639-53. [PubMed: 7777346]

22.

de Jong MA, Luder A, Gross M. Main Aspects of Peripheral and Central Hearing System Involvement in Unexplained HIV-Related Hearing Complaints. Front Neurol. 2019;10:845. [PMC free article: PMC6691119] [PubMed: 31447765]

23.

Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol. 2007 Feb;20(1):40-6. [PubMed: 17215687]

24.

Tunny TJ, Klemm SA, Gordon RD. Some aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism. Clin Exp Pharmacol Physiol. 1990 Mar;17(3):167-71. [PubMed: 2160340]

25.

Gibson WPR. Meniere's Disease. Adv Otorhinolaryngol. 2019;82:77-86. [PubMed: 30947172]

26.

Davis LE. Acute Bacterial Meningitis. Continuum (Minneap Minn). 2018 Oct;24(5, Neuroinfectious Disease):1264-1283. [PubMed: 30273239]

27.

Rodenburg-Vlot MB, Ruytjens L, Oostenbrink R, Goedegebure A, van der Schroeff MP. Systematic Review: Incidence and Course of Hearing Loss Caused by Bacterial Meningitis: In Search of an Optimal Timed Audiological Follow-up. Otol Neurotol. 2016 Jan;37(1):1-8. [PubMed: 26649601]

28.

Kopelovich JC, Germiller JA, Laury AM, Shah SS, Pollock AN. Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging. Arch Otolaryngol Head Neck Surg. 2011 May;137(5):441-7. [PMC free article: PMC3670148] [PubMed: 21339394]

29.

Berg HM, Cohen NL, Hammerschlag PE, Waltzman SB. Acoustic neuroma presenting as sudden hearing loss with recovery. Otolaryngol Head Neck Surg. 1986 Jan;94(1):15-22. [PubMed: 3081851]

30.

Seemungal BM, Bronstein AM. A practical approach to acute vertigo. Pract Neurol. 2008 Aug;8(4):211-21. [PubMed: 18644907]

31.

Fishman JM, Burgess C, Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev. 2011 May 11;(5):CD008607. [PubMed: 21563170]

32.

Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, Bense S, Theil D, Jahn K, Brandt T. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004 Jul 22;351(4):354-61. [PubMed: 15269315]

33.

Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl. 2002;(548):38-43. [PubMed: 12211356]

34.

Chan YM, Adams DA, Kerr AG. Syphilitic labyrinthitis--an update. J Laryngol Otol. 1995 Aug;109(8):719-25. [PubMed: 7561492]

35.

Bouccara D, Rubin F, Bonfils P, Lisan Q. [Management of vertigo and dizziness]. Rev Med Interne. 2018 Nov;39(11):869-874. [PubMed: 29496272]

36.

Esmaili AA, Renton J. A review of tinnitus. Aust J Gen Pract. 2018 Apr;47(4):205-208. [PubMed: 29621860]

37.

Weidt S, Delsignore A, Meyer M, Rufer M, Peter N, Drabe N, Kleinjung T. Which tinnitus-related characteristics affect current health-related quality of life and depression? A cross-sectional cohort study. Psychiatry Res. 2016 Mar 30;237:114-21. [PubMed: 26850646]

38.

McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015 Jan 13;1:CD005397. [PubMed: 25581507]

39.

Cohen HS, Kimball KT. Decreased ataxia and improved balance after vestibular rehabilitation. Otolaryngol Head Neck Surg. 2004 Apr;130(4):418-25. [PubMed: 15100637]

40.

Le TN, Westerberg BD, Lea J. Vestibular Neuritis: Recent Advances in Etiology, Diagnostic Evaluation, and Treatment. Adv Otorhinolaryngol. 2019;82:87-92. [PubMed: 30947184]

41.

Wright T. Menière's disease. BMJ Clin Evid. 2015 Nov 05;2015 [PMC free article: PMC4636025] [PubMed: 26545070]

42.

Bhattacharyya N, Gubbels SP, Schwartz SR, Edlow JA, El-Kashlan H, Fife T, Holmberg JM, Mahoney K, Hollingsworth DB, Roberts R, Seidman MD, Steiner RW, Do BT, Voelker CC, Waguespack RW, Corrigan MD. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017 Mar;156(3_suppl):S1-S47. [PubMed: 28248609]

43.

Edlow JA, Gurley KL, Newman-Toker DE. A New Diagnostic Approach to the Adult Patient with Acute Dizziness. J Emerg Med. 2018 Apr;54(4):469-483. [PMC free article: PMC6049818] [PubMed: 29395695]

44.

Strasilla C, Sychra V. [Imaging-based diagnosis of vestibular schwannoma]. HNO. 2017 May;65(5):373-380. [PubMed: 27534761]

45.

Mazón M, Pont E, Montoya-Filardi A, Carreres-Polo J, Más-Estellés F. Inner ear malformations: a practical diagnostic approach. Radiologia. 2017 Jul-Aug;59(4):297-305. [PubMed: 28040203]

46.

Schubl SD, Klein TR, Robitsek RJ, Trepeta S, Fretwell K, Seidman D, Gottlieb M. Temporal bone fracture: Evaluation in the era of modern computed tomography. Injury. 2016 Sep;47(9):1893-7. [PubMed: 27387791]

47.

Chen XH, Zeng CJ, Fang ZM, Zhang R, Cheng JM, Lin C. The Natural History of Labyrinthine Hemorrhage in Patients With Sudden Sensorineural Hearing Loss. Ear Nose Throat J. 2019 Jun;98(5):E13-E20. [PubMed: 30909739]

48.

Chovanec M, Fík Z. Tumors of the temporal bone. Cas Lek Cesk. 2019 Winter;158(6):248-252. [PubMed: 31931585]

49.

Di Stadio A, Dipietro L, Ralli M, Meneghello F, Minni A, Greco A, Stabile MR, Bernitsas E. Sudden hearing loss as an early detector of multiple sclerosis: a systematic review. Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4611-4624. [PubMed: 30058696]

50.

Aminpour S, Tinling SP, Brodie HA. Role of tumor necrosis factor-alpha in sensorineural hearing loss after bacterial meningitis. Otol Neurotol. 2005 Jul;26(4):602-9. [PubMed: 16015154]

51.

Ge NN, Brodie HA, Tinling SP. Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase. Otol Neurotol. 2008 Dec;29(8):1061-7. [PubMed: 18849884]

52.

Hartnick CJ, Kim HH, Chute PM, Parisier SC. Preventing labyrinthitis ossificans: the role of steroids. Arch Otolaryngol Head Neck Surg. 2001 Feb;127(2):180-3. [PubMed: 11177035]

53.

Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008 Jun;29(4):453-60. [PubMed: 18401285]

54.

Barkdull GC, Vu C, Keithley EM, Harris JP. Cochlear microperfusion: experimental evaluation of a potential new therapy for severe hearing loss caused by inflammation. Otol Neurotol. 2005 Jan;26(1):19-26. [PubMed: 15699715]

55.

Klein M, Koedel U, Pfister HW, Kastenbauer S. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol. 2003 Oct;54(4):451-8. [PubMed: 14520656]

56.

Rizvi I, Garg RK, Malhotra HS, Kumar N, Sharma E, Srivastava C, Uniyal R. Ventriculo-peritoneal shunt surgery for tuberculous meningitis: A systematic review. J Neurol Sci. 2017 Apr 15;375:255-263. [PubMed: 28320142]

57.

Hermann R, Ionescu EC, Dumas O, Tringali S, Truy E, Tilikete C. Bilateral Vestibulopathy: Vestibular Function, Dynamic Visual Acuity and Functional Impact. Front Neurol. 2018;9:555. [PMC free article: PMC6048872] [PubMed: 30042725]

58.

Bloch SL, McKenna MJ, Adams J, Friis M. Labyrinthitis Ossificans: On the Mechanism of Perilabyrinthine Bone Remodeling. Ann Otol Rhinol Laryngol. 2015 Aug;124(8):649-54. [PubMed: 25757630]

59.

Laulajainen Hongisto A, Jero J, Markkola A, Saat R, Aarnisalo AA. Severe Acute Otitis Media and Acute Mastoiditis in Adults. J Int Adv Otol. 2016 Dec;12(3):224-230. [PubMed: 27895000]

Disclosure: David Barkwill declares no relevant financial relationships with ineligible companies.

Disclosure: Rubeena Arora declares no relevant financial relationships with ineligible companies.